Freundlich, Michael <br/><br/>
Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.  [electronic resource] 

 -  American journal of hypertension  May 2014 
 - 720-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-7225 
<br/><br/><label>Standard No.: </label>10.1093/ajh/hpt177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Blood Pressure--drug effects<br/>Cardiomegaly--genetics<br/>Disease Models, Animal<br/>Down-Regulation<br/>Enalapril--pharmacology<br/>Ergocalciferols--pharmacology<br/>Fibroblast Growth Factors--metabolism<br/>Hypertension--etiology<br/>Male<br/>Myocardium--metabolism<br/>Nephrectomy<br/>RNA, Messenger--metabolism<br/>Rats, Sprague-Dawley<br/>Receptor, Fibroblast Growth Factor, Type 1--drug effects<br/>Renin-Angiotensin System--drug effects<br/>Uremia--drug therapy